Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment
Bausch Health Companies Inc. (NYSE:BHC) is one of the most undervalued Canadian stocks to buy now.
Durect Corp (DRRX)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Dalton Investments Gifford Combs | 745,000 | $473,224 | +46% | 0.25% |
| 2. | Renaissance Technologies Jim Simons | 177,766 | $112,917 | +4% | 0% |
| 3. | Ironwood Investment Management Warren Isabelle | 118,106 | $75,021 | -28% | 0.04% |
| 4. | 17,900 | $11,370 | -59% | 0% | |
| 5. | Ancora Advisors Frederick Disanto | 1,600 | $1,016 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.92 | 5,917 | $11,357.09 | 2,672,529 | 2025-08-22 | Filing | |
| $1.90 | 116,612 | $221,306.25 | 2,666,612 | 2025-08-21 | Filing | |
| $1.89 | 87,608 | $165,360.10 | 970,000 | 2025-08-20 | Filing | |
| $0.85 | 9,412 | $8,000.00 | 356,132 | 2022-08-19 | Filing | |
| $0.85 | 71,531 | $60,794.20 | 346,720 | 2022-08-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.06 | 9,000 | $9,495.00 | 0 | 2021-12-10 | Filing | |
| $1.72 | 60,137 | $103,682.20 | 34,832 | 2021-05-14 | Filing | |
| $1.68 | 250,000 | $420,000.00 | 26,414,656 | 2020-09-01 | Filing | |
| $2.45 | 22,956 | $56,283.52 | 32,747 | 2020-06-03 | Filing | |
| $2.45 | 34,864 | $85,479.56 | 32,747 | 2020-06-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
DURECT Corporation (NASDAQ:DRRX) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the DURECT Corporation Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
DURECT Corporation (NASDAQ:DRRX) Q3 2024 Earnings Call Transcript
Operator: Greetings! And welcome to the DURECT Corporation Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
DURECT Corporation (NASDAQ:DRRX) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to the DURECT Corporation Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
DURECT Corporation (NASDAQ:DRRX) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the DURECT Corporation First Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript
DURECT Corporation beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.36.
10 Oversold Penny Stocks To Buy
As markets rebound on the back of declining inflation and hopes that the Federal Reserve might be close to winning its battle against inflation, investors are eagerly looking for investing opportunities...
5 Most Promising Penny Stocks According to Analysts
Germany-based Affimed N.V. (NASDAQ:AFMD) is working on cancer immunotherapies. Affimed N.V.
DURECT Corporation (NASDAQ:DRRX) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the DURECT Corporation Second Quarter Earnings Call. [Operator Instructions]. It is now my pleasure to introduce your host, Tim Papp, Chief Financial Officer.
10 Best Rated Penny Stocks to Buy According to Analysts
Investing in small companies, penny stocks, micro-cap or even small-cap companies went out of fashion as soon as the financial markets started to take a beating amid interest rate hikes.